Sartorius Stedim Biotech takes majority stake in AllPure Technologies

Published: 29-Apr-2014
Finance

Takeover extends portfolio for single-use bioprocessing


Sartorius Stedim Biotech (SSB), an international supplier to the pharmaceutical and biotech industries, has agreed to take a majority stake in US start-up company AllPure Technologies, based in New Oxford, Pennsylvania.

AllPure, which employs 25 people, has been operating for four years and in 2013 earned revenue of around US$3m. The company specialises in single-use components for biopharmaceutical applications, such as aseptic sampling techniques.

No financial terms have been disclosed.

Reinhard Vogt, a member of SSB’s Executive Board, said: 'AllPure further completes our portfolio with innovative products that help our customers develop and manufacture their pharmaceutical drugs safer and more efficiently.'

Sartorius Stedim Biotech offers integrated solutions covering fermentation, cell cultivation, filtration, purification, fluid management and lab technologies to the pharmaceutical and biopharmaceutical industries.

  • Companies:
  • Sartorius
See more

You may also like

Finance

MarkHerz and Polyplus collaborate to advance CGT process standards and lower costs

Read more
Polyplus (part of Sartorius) has inked a collaboration with pioneering Korean cell and gene therapy (CGT) CDMO, MarkHerz, to set new CGT efficiency standards focused on decreasing cost and increasing quality per dose of a therapeutic product

Trending Articles

  1. Lonza Capsules & Health Ingredients expands capsule manufacturing capacity in India and China New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari (IN) and Suzhou (CN), highlighting the long-term strategic commitment to the business and the APAC region
  2. Novo Holdings completes acquisition of Catalent Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark
  3. Newcells Biotech raises additional funding from investors Newcells Biotech, a leading drug discovery partner specialising in the development of in vitro models and bespoke assay services to improve the prediction of in vivo human outcomes, has raised a further £1.2m from existing investors Mercia Ventures, Northstar Ventures and North East Finance
  4. ACG expands global footprint with new capsule manufacturing facility in Thailand New capsule manufacturing facility in Rayong, Thailand, is strategically positioned to serve key Asian markets
  5. £20m Scottish oligonucleotide manufacturing innovation centre now under construction The centre will act as an innovation centre, assisting in the development and optimisation of oligonucleotide manufacturing processes, while also bolstering the UK's biopharmaceutical presence

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Finance

MarkHerz and Polyplus collaborate to advance CGT process standards and lower costs

Polyplus (part of Sartorius) has inked a collaboration with pioneering Korean cell and gene therapy (CGT) CDMO, MarkHerz, to set new CGT efficiency standards focused on decreasing cost and increasing quality per dose of a therapeutic product
Manufacturing

Sartorius and Repligen combine technologies for integrated bioreactor system

The two companies have incorporated Repligen XCell ATF upstream intensification technology into Sartorius’ Biostat STR bioreactor to simplify upstream process intensification
Manufacturing

Sartorious to acquire plasmid manufacturer Polyplus

Polyplus develops and produces transfection as well as other DNA/RNA delivery reagents and plasmid DNA in high quality and GMP grade
Ingredients

Sartorius makes $500m acquisition of biopharma component manufacturer

The life science group's French subgroup Sartorius Stedim Biotech has agreed to acquired UK-based Albumedix to be part of the Bioprocess Solutions Division
Manufacturing

Sartorius and HOF Sonderanlagenbau partner on freeze-thaw products

“With this partnership, Sartorius continues to strengthen its leading position in the freeze-thaw market,” said Eva Lindskog, Head of Fluid Management Technologies at Sartorius
Finance

Sartorius to open manufacturing facility in Hampshire

With the Havant facility, Sartorius now has five locations in the UK, employing over 900 staff members
Research & Development

RoosterBio partners with Sartorius on scale up protocols

Both companies aim to use the data from this collaboration to provide co-learning and development opportunities to support the growing cell and gene therapy industry
Subscribe now